Tue. 7 May 2024, 5:02pm ET
Benzinga
Earnings, Earnings Misses, News
Immuneering (NASDAQ:IMRX) reported quarterly losses of $(0.49) per share which missed the analyst consensus estimate of $(0.46) by 6.52 percent. This is a 3.92 percent increase over losses of $(0.51) per share from the same period last year.